Sfoglia per Autore
Contributo della tomografia assiale computerizzata nella condrocalcinosi del ginocchio
1998-01-01 G. Cherie Ligniere, G. Santalena, E. Favalli, E. Luna
Haemostatic and inflammatory biomarkers in patients with rheumatoid arthritis : effect of tumor necrosis factor alpha blockade
2007-01-01 M. Cugno, F. Ingegnoli, E. Favalli, A. Soldi, S. Griffini, E. Bonanni, V. Galbiati, F. Fantini
Effect of tumor necrosis factor alpha blockade on inflammatory and haemostatic biomarkers in patients with rheumatoid arthritis
2007-01-01 F. Ingegnoli, M. Cugno, E. Favalli, A. Soldi, S. Griffini, E. Bonanni, V. Galbiati, F. Fantini
Reduction of haemostatic and inflammatory biomarkers by tumor necrosis factor-alpha bockade in patients with rheumatoid arthritis
2007-03-01 F.A. Ingegnoli, M. Cugno, E. Favalli, A. Soldi, S. Griffini, E. Bonanni, F. Fantini
Inflammatory and prothrombotic biomarkers in patients with rheumatoid arthritis : effects of tumor necrosis factor-alpha blockade
2008-01-01 F. Ingegnoli, F. Fantini, E.G. Favalli, A. Soldi, S. Griffini, V. Galbiati, P. Meroni, M. Cugno
Effetto della terapia con infliximab sui marcatori di infiammazione, coagulazione e fibrinolisi nell’artrite reumatoide
2008-01-01 F. Ingegnoli, M. Cugno, V. Galbiati, A. Soldi, E.G. Favalli, S. Griffini, P.L. Meroni, F. Fantini
Activation of inflammation, coagulation and fibrinolysis in patients with Rheumatoid Arthritis : inhibition by Tumor Necrosis Factor alpha blockade
2008-01-01 F.A. Ingegnoli, F. Fantini, E.G. Favalli, V. Galbiati, A. Soldi, S. Griffini, E. Bonanni, M. Cugno
Efficacy and safety of anti-TNF agents in the Lombardy rheumatoid arthritis network (LORHEN) = Efficacia e sicurezza degli agenti anti-TNF nel registro Lombardo (LORHEN)
2008-01-01 P. Sarzi-Puttini, M. Antivalle, A. Marchesoni, E. Favalli, R. Gorla, M. Filippini, R. Caporali, F. Bobbio-Pallavicini, C. Montecucco, F. Atzeni
Haemostatic and inflammatory biomarkers in patients with active Rheumatoid Arthritis : effects of Tumor Necrosis Factor alpha blockade
2008-01-01 F. Ingegnoli, F. Fantini, V. Galbiati, A. Soldi, R. Gualtierotti, S. Griffini, E.G. Favalli, M. Cugno
Predicting response to anti-TNF treatment in rheumatoid arthritis patients
2009-01-01 F. Atzeni, M. Antivalle, F.B. Pallavicini, R. Caporali, C. Bazzani, R. Gorla, E.G. Favalli, A. Marchesoni, P. Sarzi-Puttini
TNF-α antagonist survival rate in a cohort of rheumatoid arthritis patients observed under conditions of standard clinical practice
2009-01-01 A. Marchesoni, E. Zaccara, R. Gorla, C. Bazzani, P. Sarzi-Puttini, F. Atzeni, R. Caporali, F. Bobbio-Pallavicini, E.G. Favalli
Treatment of rheumatoid arthritis with anti-TNF-alpha agents : a reappraisal
2009-01-01 R. Caporali, F. Pallavicini, M. Filippini, R. Gorla, A. Marchesoni, E. Favalli, P. Sarzi Puttini, F. Atzeni, C. Montecucco
Serious infections during anti-TNFalpha treatment in rheumatoid arthritis patients
2009-01-01 E. Favalli, F. Desiati, F. Atzeni, P. Sarzi Puttini, R. Caporali, F. Bobbio Pallavicini, R. Gorla, M. Filippini, A. Marchesoni
Anti-TNFα therapy in a cohort of rheumatoid arthritis patients : clinical outcomes
2009-01-01 C. Bazzani, M. Filippini, R. Caporali, F. Pallavicini, E. Favalli, A. Marchesoni, F. Atzeni, P. Sarzi Puttini, R. Gorla
Tumour necrosis factor antagonist therapy and cancer development : analysis of the LORHEN registry
2010-01-01 F. Pallavicini, R. Caporali, P. Sarzi-Puttini, F. Atzeni, C. Bazzani, R. Gorla, A. Marchesoni, E. Favalli, C. Montecucco
Switching TNF-alpha antagonists in rheumatoid arthritis: the experience of the LORHEN registry
2010-01-01 R. Caporali, P. Sarzi-Puttini, F. Atzeni, R. Gorla, M. Filippini, A. Marchesoni, E. Favalli, F. Bobbio-Pallavicini, C. Montecucco
Efficacy and Safety of Anti-Tumour Necrosis Factor in Elderly Patients with Rheumatoid Arthritis : an Observational Study
2010-01-01 M. Filippini, C. Bazzani, E.G. Favalli, A. Marchesoni, F. Atzeni, P. Sarzi-Puttini, F.B. Pallavicini, R. Caporali, R. Gorla
Patient preferences in the choice of anti-TNF therapies in rheumatoid arthritis. Results from a questionnaire survey (RIVIERA study)
2010-02-01 S. Scarpato, M. Antivalle, E.G. Favalli, F. Nacci, S. Frigelli, F. Bartoli, L. Bazzichi, G. Minisola, B. Marasini, M. Matucci Cerinic
Recommendations for the use of biologic therapy in rheumatoid arthritis: update from the Italian Society for Rheumatology II. Safety
2011-01-01 E. Favalli, R. Caporali, L. Sinigaglia, N. Pipitone, I. Miniati, C. Montecucco, M. Matucci-Cerinic
The role of biologic agents in damage progression in rheumatoid arthritis: indirect comparison of data coming from randomized clinical trials
2012-08-01 E.G. Favalli, F. Pregnolato, M. Biggioggero, P.L. Meroni
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile